Jean-Antoine Ribeil

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Vertex Therapeutics
    Topic:
    Consulting for Medical Affair about gene therapy
    Date added:
    03/23/2026
    Date updated:
    03/23/2026
    Relationship end date:
    08/31/2025
  • Attribution:
    Spouse or Partner
    Type of financial relationship:
    Employment
    Ineligible company:
    Xylio Therapeutics
    Topic:
    Scientific Director
    Date added:
    03/23/2026
    Date updated:
    03/23/2026
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    bluebirdbio
    Topic:
    gene therapy company stock from previous employement
    Date added:
    03/23/2026
    Date updated:
    03/23/2026
    Relationship end date:
    06/30/2025
Return to 109 Division Of Hem/Onc: Combined Modality Conference "Academic Half Day" (032626)

 

**Disclaimer**

This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.